HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term results of valve implants in filtering surgery for eyes with neovascular glaucoma.

Abstract
Filtration surgery was performed with a pressure-sensitive, unidirectional valve implant in 79 eyes with neovascular glaucoma. The device consisted of an open Supramid tube (outside diameter 0.58 mm) sealed to a Silastic tube with a slit valve. The Supramid tube was inserted at the corneoscleral limbus 1 to 4 mm into the anterior chamber. The Silastic portion was located under a scleral flap. Of the 79 eyes, 53 had postoperative intraocular pressures less than or equal to 24 mm Hg after a mean follow-up period of 23.7 +/- 10.9 months. Bleb revision for external scarring was required in ten of these 53 eyes and postoperative medical therapy was required in 26. The valve implant failed to control intraocular pressure in 26 of the 79 eyes. Failure was secondary to scarring of the external bleb in 18 eyes and to closure of the internal Supramid tube in five eyes. Mortality during the follow-up period was high: 12 of the 53 successfully treated patients and five of the unsuccessfully treated patients died.
AuthorsT Krupin, P Kaufman, A I Mandell, S A Terry, R Ritch, S M Podos, B Becker
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 95 Issue 6 Pg. 775-82 (Jun 1983) ISSN: 0002-9394 [Print] United States
PMID6190402 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Silicone Elastomers
Topics
  • Adolescent
  • Adult
  • Aged
  • Anterior Chamber (surgery)
  • Female
  • Glaucoma (surgery)
  • Humans
  • Intraocular Pressure
  • Male
  • Middle Aged
  • Neovascularization, Pathologic
  • Prostheses and Implants
  • Silicone Elastomers
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: